|
|
 |
International Clinical Trials in Neurology
Australia
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Adelaide, South Australia; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Brisbane, Queensland; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Concord, New South Wales; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Fitzroy; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Adelaide; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Brisbane, Queensland; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Chatswood, New South Wales; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Clayton, Victoria; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Fitzroy, Victoria; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Maroochydore, Queensland; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Parkville, Victoria; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
West Heidelberg; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Woodville, South Australia; UCB Clinical Trial Call Center
Austria
Belgium
Brazil
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Campinas; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Curitiba; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Florianópolis; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Porto Alegre; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Ribeirao Pret; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Salvador; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Sao Jose do Rio Preto; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Sao Paulo; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Sao Paulo; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Sao Paulo; UCB Clinical Trial Call Center
Canada
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Montreal, Quebec; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Quebec, QC; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Vancouver, BC; UCB Clinical Trial Call Center
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Calgary, Alberta; University of Calgary - Foothills Hospital
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Hamilton, Ontario; St. Joseph Healthcare
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Montreal, Quebec; Montreal Heart Institute
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Quebec City, Quebec; Centre Hospitalier Universitaire de Quebec
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Toronto, Ontario; Davisville Medical Center
- Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
Various Cities; Research Site
- Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
Various Cities; Research Site
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Edmonton, Alberta; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Greenfield Park, Quebec; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Montreal, Quebec; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Montreal, Quebec; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Quebec City, Quebec; UCB Clinical Trial Call Center
Czech Republic
Denmark
Finland
France
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Angers Cedex 9; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bethune; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bron; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Dijon; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lille; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Montpellier Cedex; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Nancy; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Paris; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Paris; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Reims; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Rennes; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Roanne; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Strasbourg; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Angers Cedex 1; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bethune; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bron; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Dijon; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lyon; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Marseille; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Montpellier Cedex 5; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Paris; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Rennes; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
St Pierre Cedex; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Strasbourg; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Toulouse Cedex 04; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Amiens; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Lille; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Paris; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Reims; UCB Clinical Trial Call Center
Germany
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Berlin; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bernau; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Bielefeld; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Erlangen; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Göttingen; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
Jena; UCB Clinical Trial Call Center
- Epilepsy: Brivaracetam as Add-on Treatment in Adolescents and Adults Suffering From Epilepsy
München; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bad Berka; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Berlin; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Freiburg; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kehl, Kork; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Liegau-Augustusbad; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Mainz; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Munchen; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Ulm; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Berlin; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Berlin; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bonn; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Frankfurt; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Freiburg; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Gottingen; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Jena; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Kehl; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Munchen; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Munchen; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Heidelberg; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Kehl; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy
Kiel; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Heidelberg; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kehl; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Kiel; UCB Clinical Trial Call Center
- Epilepsy: Open-Label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy
Münster; UCB Clinical Trial Call Center
- Migraine and Cluster Headaches: Percitaneous Closure of Patent Foramen Ovale in Migraine with Aura - A Randomized Prospective Study: PRIMA Migraine Clinical Trial
Münster; Universitätsklinicum Munster
- Migraine and Cluster Headaches: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
Various Cities; Research Site
- Narcolepsy: Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Schwalmstadt; UCB Clinical Trial Call Center
- Neurologic Disorders: Whether subjects with percutaneous PFO closure experience a reduction in migraine attacks.
Various Cities; Research Site
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Berlin; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Dresden; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Kassel; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Leipzig; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Marburg; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Munchen; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Naumburg; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Oranienburg; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Ulm; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Wolfach; UCB Clinical Trial Call Center
Hong Kong
Hungary
India
Ireland
Israel
Italy
Mexico
- Epilepsy: The purpose of this research program is to assess the effectiveness and safety of a study drug in patients with PGTC Seizures.
San Juan, PR; Research Site
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Aguascalientes; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Distrio federal; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Guadalajara; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Guadalajara Jalisco; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Aguascalientes; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Chihuahua; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Mexico City; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Mexico DF; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Mexico, DF; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Monterrey; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Monterrey, NL; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Nuevo Leon; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Nuevo León; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
San Luis Potosi; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Valle Oriente Garza Garcia; UCB Clinical Trial Call Center
- Seizure Disorders: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Zapopan, Jalisco; UCB Clinical Trial Call Center
Netherlands
New Zealand
Norway
Poland
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Bialystok; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Gdansk; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Katowice; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Kielce; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lodz; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Lublin; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Szczecin; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warsaw; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warszawa; UCB Clinical Trial Call Center
- Epilepsy: Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Warszawa; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Bialystok; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Gdansk; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Katowice; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Kielce; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lodz; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lodz; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Lublin; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Szczecin; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warsaw; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warszawa; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warszawa; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warszawa; UCB Clinical Trial Call Center
- Epilepsy: Follow-up Trial to Evaluate Long-Term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy
Warszawa; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Gdansk; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Krakow; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Lublin; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Olsztyn; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa; UCB Clinical Trial Call Center
- Parkinson's Disease: Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine
Warszawa; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Bialystok; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Gdansk; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Katowice; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Krakow; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Lodz; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Lublin; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Poznan; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Poznan; UCB Clinical Trial Call Center
- Seizure Disorders: Conversion to Monotherapy Study With Keppra XR for Partial Seizures
Warszawa; UCB Clinical Trial Call Center
Portugal
Puerto Rico
Russian Federation
Serbia and Montenegro
Singapore
South Africa
South Korea
Spain
Sweden
Sweeden
Switzerland
Tunisia
Ukraine
United Kingdom
|
 |

Back to CWWorld
 CenterWatch Clinical Research Training Series
|